Additionally, amino acids from protein digestion may trigger GLP-1 receptors, contributing to the proteins satiating effect
Not as a standalone cosmetic intervention
Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes
doi:10.1016/j.mad.2003.11.005 Huff T, Mller CS, Otto AM, Netzker R, Hannappel E
Jan 2015;94(1):65-71
Pre-diabetes panel: Tests only A1C